Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
66.4M
-
Number of holders
-
101
-
Total 13F shares, excl. options
-
42.6M
-
Shares change
-
-112K
-
Total reported value, excl. options
-
$835M
-
Value change
-
-$3.43M
-
Number of buys
-
48
-
Number of sells
-
-55
-
Price
-
$19.58
Significant Holders of RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) as of Q2 2021
132 filings reported holding RYTM - RHYTHM PHARMACEUTICALS, INC. - COM as of Q2 2021.
RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) has 101 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 42.6M shares
of 66.4M outstanding shares and own 64.18% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (6.15M shares), NEA Management Company, LLC (4.91M shares), JANUS HENDERSON GROUP PLC (3.93M shares), BAKER BROS. ADVISORS LP (3.86M shares), BlackRock Inc. (3.34M shares), FEDERATED HERMES, INC. (3.02M shares), VANGUARD GROUP INC (2.26M shares), STATE STREET CORP (2.18M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1.99M shares), and GILDER GAGNON HOWE & CO LLC (1.49M shares).
This table shows the top 101 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.